BPH and sexuality.
Quality of life has become a very important parameter in benign prostatic hyperplasia (BPH) and one of the major concepts identified by the patients to be important is related to sexuality after BPH therapy. The impact on sexuality resulting from the various treatment modalities of BPH, either medical, surgical or instrumental has been too often neglected in the past and poorly investigated. The present article reviews the influence on sexual function of current therapies for symptomatic BPH.
Department of Urology, Erasme Hospital, University Clinics of Brussels, Belgium.
A R
AR
Zlotta
C C
CC
Schulman
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D007172:Erectile Dysfunction / Q000139:chemically induced / Q000209:etiology*; D006801:Humans; D007989:Libido; D008297:Male; D011468:Prostatectomy / Q000009:adverse effects*; D011470:Prostatic Hyperplasia / Q000628:therapy*; D011788:Quality of Life
D000317:Adrenergic alpha-Antagonists